Trial
NCT04386252
Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Aivita Biomedical, Inc.
Collaborators
—
Condition
COVID-19
Intervention
AV-COVID-19
Why stopped
The FDA put our protocol on clinical hold and never gave an okay to start, so we decided not to proceed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-03